In the last decades, it has become clear that adiponectin is an essential regulator of glucose and lipid metabolism and a great influencer of the risk for developing obesity, T2D, CVD and, therefore, for MS. The gene discussed is ADIPOQ; the disease is myeloid sarcoma.